Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer

Immune checkpoint inhibitor (ICI) therapy has revolutionized the breast cancer treatment landscape. However, ICI-induced systemic inflammatory immune-related adverse events (irAE) remain a major clinical challenge. Previous studies in our laboratory and others have demonstrated that a high-salt (HS)...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Durga Khandekar, Debolanle O. Dahunsi, Isaac V. Manzanera Esteve, Sonya Reid, Jeffrey C. Rathmell, Jens Titze, Venkataswarup Tiriveedhi
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-05-01
סדרה:	Biology
נושאים:	breast cancer immunotherapy t-helper cells cytokines cancer biology
גישה מקוונת:	https://www.mdpi.com/2079-7737/11/6/810
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!